BICENTRIC PILOT STUDY ON AGE‐ADAPTED HIGH‐DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA PATIENTS > 65 YEARS ‐ MARiTA TRIAL. (12th June 2019)